Life Sciences
The online pharmacy is partnering with GSK, Kaléo, Novo Nordisk and Dexcom to include coupons for their brand-name medications.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
The antiviral medication was found to interact with over 2,000 prescription drugs.
The collaboration will expand MedArrive's maternal care services for managed Medicaid health plan members.
There could be drug misuse and adverse side effects and drug interactions with mobile app prescribing.
Also, Intellect has secured undisclosed investment from IHH Healthcare for its regional expansion.
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
HIMSS23
Wendy Paul, medication process architect at Seattle Children's Hospital, and Kyle Longhurst, product manager at Pariveda, preview their HIMSS23 discussion on a discharge medication error quality improvement project.
Epigenetic profiling creates opportunities for healthcare and the development of new drugs based on it, according to Mohamad Takwa, CEO of Epigenica, a Sweden-based company that focuses on the technology.
Also, EpiSoft announces the integration of its cancer management platform with My Health Record.